Fig. 5From: Design of PSMA ligands with modifications at the inhibitor part: an approach to reduce the salivary gland uptake of radiolabeled PSMA inhibitors?Tumor-to-tissue ratios of [177Lu]Lu-PSMA-10 ([177Lu]Lu-1), [177Lu]Lu-3, [177Lu]Lu-10 and [177Lu]Lu-11 in selected organs at 24 h p.i. (n = 4 for [177Lu]Lu-10 and n = 5 for all other experiments)Back to article page